Dr. Vivek Vyas
Dr. Vivek Vyas
Assistant Professor
Verified email at nirmauni.ac.in
TitleCited byYear
Homology modeling a fast tool for drug discovery: current perspectives
VK Vyas, RD Ukawala, M Ghate, C Chintha
Indian journal of pharmaceutical sciences 74 (1), 1, 2012
1532012
Therapeutic potential of snake venom in cancer therapy: current perspectives
VK Vyas, K Brahmbhatt, H Bhatt, U Parmar
Asian Pacific journal of tropical biomedicine 3 (2), 156-162, 2013
1182013
Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors
V K Vyas, M Ghate
Mini reviews in medicinal chemistry 11 (12), 1039-1055, 2011
792011
Virtual screening: a fast tool for drug design
V Vyas, A Jain, A Jain, A Gupta
Scientia Pharmaceutica 76 (3), 333-360, 2008
652008
Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors
VK Vyas, M Ghate, A Goel
Journal of Molecular Graphics and Modelling 42, 17-25, 2013
492013
Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review
V K Vyas, M Ghate
Mini reviews in medicinal chemistry 10 (14), 1366-1384, 2010
372010
Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives
P Srivastava, VK Vyas, B Variya, P Patel, G Qureshi, M Ghate
Bioorganic chemistry 67, 130-138, 2016
262016
Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and …
VK Vyas, B Variya, MD Ghate
European journal of medicinal chemistry 82, 385-393, 2014
262014
Development and validation of a stability-indicating reversed-phase HPLC method for simultaneous estimation of rosuvastatin and ezetimibe from their combination dosage forms
AKK Gajjar, VDD Shah
Eurasian journal of analytical chemistry 5 (3), 265-283, 2010
222010
Ligand and structure-based approaches for the identification of SIRT1 activators
VK Vyas, A Goel, M Ghate, P Patel
Chemico-biological interactions 228, 9-17, 2015
212015
CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents
VK Vyas, HG Bhatt, PK Patel, J Jalu, C Chintha, N Gupta, M Ghate
SAR and QSAR in Environmental Research 24 (7), 519-551, 2013
192013
Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity
SV Bhadada, VK Vyas, RK Goyal
Biomedicine & Pharmacotherapy 83, 221-228, 2016
182016
CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
V K Vyas, M Ghate
Current computer-aided drug design 8 (4), 271-282, 2012
152012
CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
V K Vyas, M Ghate
Current computer-aided drug design 8 (4), 271-282, 2012
152012
Biology and medicinal chemistry approaches towards various apoptosis inducers
V K Vyas, C Chintha, M R Pandya
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013
132013
2D and 3D QSAR study on amino nicotinic acid and isonicotinic acid derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH)
VK Vyas, M Ghate
Medicinal Chemistry Research 21 (10), 3021-3034, 2012
132012
Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor
VK Vyas, M Ghate, K Patel, G Qureshi, S Shah
Biomedicine & Pharmacotherapy 74, 42-48, 2015
122015
Recent advances in characterization of impurities-Use of hyphenated LC-MS technique
V K Vyas, M Ghate, R D Ukawala
Current Pharmaceutical Analysis 6 (4), 299-306, 2010
122010
Predictive 3D-QSAR and HQSAR model generation of isocitrate lyase (ICL) inhibitors by various alignment methods combined with docking study
N Gupta, VK Vyas, B Patel, M Ghate
Medicinal Chemistry Research 23 (6), 2757-2768, 2014
92014
Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II–AT1 receptor antagonists based on …
VK Vyas, N Gupta, M Ghate, S Patel
SAR and QSAR in Environmental Research 25 (2), 117-146, 2014
82014
The system can't perform the operation now. Try again later.
Articles 1–20